Z79.890Hormone replacement therapy

Z79.890 is the ICD-10-CM diagnosis code for hormone replacement therapy. It belongs to category Z79 (long term (current) drug therapy), block Z77-Z99 (persons with potential health hazards related to family and personal history and certain conditions influencing health status) and chapter 21 (factors influencing health status and contact with health services). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within Z79.89 (other long term (current) drug therapy), Z79.890 is specifically for hormone replacement therapy. Related codes cover long term (current) use of opiate analgesic (Z79.891) and other long term (current) drug therapy (Z79.899).

It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.

In MS-DRG v44.0, it is part of the grouping logic for DRG 951 (Other Factors Influencing Health Status, relative weight 0.5577), in MDC 23 (Factors Influencing Health Status and Other Contacts with Health Services), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It is not acceptable as the principal diagnosis for an inpatient stay; it may be reported as a secondary diagnosis.

It is exempt from present-on-admission (POA) reporting, so no POA indicator is required.

It has been part of ICD-10-CM since the code set took effect on October 1, 2015, and changed in FY2018 (title revised).

Before ICD-10, this condition was coded in ICD-9-CM as V07.4 (hormone replacement therapy (postmenopausal)).